United States Healthcare Equipment & Supplies

Caris Life Sciences, Inc. (CAI)

Caris Life Sciences experienced significant insider selling over the past ninety days, totaling approximately 27 million dollars in net value. Executives, including the President, offloaded substantial equity stakes. These divestments occurred amid a 7.8 percent stock price increase, following a positive earnings report where the company outperformed expectations by 66.7 percent.
Ticker: CAI Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Caris Life Sciences, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.6
Denton John Russel See Remarks Officer
Transaction date
Planned sale
Price
484.52
Quantity 18,181 -32.7%
Value US$4,568,112
1.6
JOHN RUSSEL DENTON Officer Officer
Transaction date
Proposed sale
Price
446.96
Quantity 78,620
Value US$927,761
Brille Brian J See Remarks Executive Director
Transaction date
Sale
Price
263.18
Quantity 43,210 -23.6%
Value US$996,280
BRIAN J BRILLE Officer; Director Executive Director
Transaction date
Proposed sale
Price
30.33
Quantity 400,000
Value US$12,132,080
1.5
Spetzler David Baxley President Officer
Transaction date
Sale
Price
24.76
Quantity 119,212 -9.2%
Value US$2,951,117
1.5
DAVID SPETZLER Officer Officer
Transaction date
Proposed sale
Price
24.76
Quantity 119,212
Value US$2,951,117
1.5
Spetzler David Baxley President Officer
Transaction date
Sale
Price
25.32
Quantity 84,900 -7.5%
Value US$2,149,676
1.5
Spetzler David Baxley President Officer
Transaction date
Sale
Price
24.76
Quantity 393,100 -25.7%
Value US$9,733,313
1.5
DAVID SPETZLER Officer Officer
Transaction date
Proposed sale
Price
24.86
Quantity 478,000
Value US$11,882,984
2.5
GEORGE H POSTE REVOCABLE TRUST Former Affiliate
Transaction date
Proposed sale
Price
26.06
Quantity 100,000
Value US$2,606,320
2.5
GEORGE H POSTE Director Non-Executive Director
Transaction date
Proposed sale
Price
21.42
Quantity 30,000
Value US$642,633
2.5
GEORGE H POSTE Director Non-Executive Director
Transaction date
Proposed sale
Price
16.25
Quantity 20,000
Value US$325,000
3.3
HALBERT JON Non-Executive Director
Transaction date
Purchase
Price
14.56
Quantity 68,000 +10.7%
Value US$990,080
3.7
Vacirca Jeff L Non-Executive Director
Transaction date
Purchase
Price
16.15
Quantity 31,050 +166.7%
Value US$501,426
Power Luke Thomas See Remarks Officer
Transaction date
Planned sale
Price
27.16
Quantity 1,400 -1.4%
Value US$38,018
Power Luke Thomas See Remarks Officer
Transaction date
Planned sale
Price
26.56
Quantity 60,850 -37.6%
Value US$1,616,444
LUKE POWER Officer Officer
Transaction date
Proposed sale
Price
27.10
Quantity 62,250
Value US$1,686,975
1.6
Denton John Russel See Remarks Officer
Transaction date
Purchase
Price
24.09
Quantity 4,184 +83.7%
Value US$100,793
1.5
Spetzler David Baxley President Officer
Transaction date
Purchase
Price
23.85
Quantity 400 +0.1%
Value US$9,540
1.6
Denton John Russel See Remarks Officer
Transaction date
Purchase
Price
21.00
Quantity 7,500 +6.5%
Value US$157,500
Brille Brian J See Remarks Executive Director
Transaction date
Purchase
Price
21.00
Quantity 30,000 +22.7%
Value US$630,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-23 2026-09-22 PlS Planned sale
1.6
Denton John Russel

See Remarks

Officer
18,181 -32.7%
484.52
US$4,568,112 		18,181 -32.7% 484.52 US$4,568,112
2026-09-22 2026-09-22 PrS Proposed sale
1.6
JOHN RUSSEL DENTON

Officer

Officer
78,620
446.96
US$927,761 		78,620 446.96 US$927,761
2026-09-17 2026-09-17 S Sale
Brille Brian J

See Remarks

Executive Director
43,210 -23.6%
263.18
US$996,280 		43,210 -23.6% 263.18 US$996,280
2026-09-17 2026-09-17 PrS Proposed sale
BRIAN J BRILLE

Officer; Director

Executive Director
400,000
30.33
US$12,132,080 		400,000 30.33 US$12,132,080
2026-09-04 2026-09-04 S Sale
1.5
Spetzler David Baxley

President

Officer
119,212 -9.2%
24.76
US$2,951,117 		119,212 -9.2% 24.76 US$2,951,117
2026-09-04 2026-09-04 PrS Proposed sale
1.5
DAVID SPETZLER

Officer

Officer
119,212
24.76
US$2,951,117 		119,212 24.76 US$2,951,117
2026-09-04 2026-09-03 S Sale
1.5
Spetzler David Baxley

President

Officer
84,900 -7.5%
25.32
US$2,149,676 		84,900 -7.5% 25.32 US$2,149,676
2026-09-04 2026-09-03 S Sale
1.5
Spetzler David Baxley

President

Officer
393,100 -25.7%
24.76
US$9,733,313 		393,100 -25.7% 24.76 US$9,733,313
2026-09-03 2026-09-03 PrS Proposed sale
1.5
DAVID SPETZLER

Officer

Officer
478,000
24.86
US$11,882,984 		478,000 24.86 US$11,882,984
2026-08-24 2026-08-24 PrS Proposed sale
2.5
GEORGE H POSTE REVOCABLE TRUST

Former Affiliate
100,000
26.06
US$2,606,320 		100,000 26.06 US$2,606,320
2026-08-07 2026-08-07 PrS Proposed sale
2.5
GEORGE H POSTE

Director

Non-Executive Director
30,000
21.42
US$642,633 		30,000 21.42 US$642,633
2026-08-03 2026-08-03 PrS Proposed sale
2.5
GEORGE H POSTE

Director

Non-Executive Director
20,000
16.25
US$325,000 		20,000 16.25 US$325,000
2026-07-13 2026-05-15 B Purchase
3.3
HALBERT JON
Non-Executive Director
68,000 +10.7%
14.56
US$990,080 		68,000 +10.7% 14.56 US$990,080
2026-05-12 2026-05-11 B Purchase
3.7
Vacirca Jeff L
Non-Executive Director
31,050 +166.7%
16.15
US$501,426 		31,050 +166.7% 16.15 US$501,426
2025-12-12 2025-12-11 PlS Planned sale
Power Luke Thomas

See Remarks

Officer
1,400 -1.4%
27.16
US$38,018 		1,400 -1.4% 27.16 US$38,018
2025-12-12 2025-12-11 PlS Planned sale
Power Luke Thomas

See Remarks

Officer
60,850 -37.6%
26.56
US$1,616,444 		60,850 -37.6% 26.56 US$1,616,444
2025-12-11 2025-12-11 PrS Proposed sale
LUKE POWER

Officer

Officer
62,250
27.10
US$1,686,975 		62,250 27.10 US$1,686,975
2025-11-10 2025-11-07 B Purchase
1.6
Denton John Russel

See Remarks

Officer
4,184 +83.7%
24.09
US$100,793 		4,184 +83.7% 24.09 US$100,793
2025-11-10 2025-11-07 B Purchase
1.5
Spetzler David Baxley

President

Officer
400 +0.1%
23.85
US$9,540 		400 +0.1% 23.85 US$9,540
2025-06-23 2025-06-20 B Purchase
1.6
Denton John Russel

See Remarks

Officer
7,500 +6.5%
21.00
US$157,500 		7,500 +6.5% 21.00 US$157,500
2025-06-23 2025-06-20 B Purchase
Brille Brian J

See Remarks

Executive Director
30,000 +22.7%
21.00
US$630,000 		30,000 +22.7% 21.00 US$630,000
Explore more

More insider trading research around Caris Life Sciences, Inc.

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America